Korean Journal of Psychosomatic Medicine (정신신체의학)

Korean Psychosomatic Society (한국정신신체의학회)
권호 표지
DOI QR코드

DOI QR Code

Result of Multiphasic Military Personality Inventory Among Grave's Disease in 19-Year-Old Men

19세 남성에서 그레이브스병의 다면적 군인성검사 결과

  • Jong Hyun, Kim (Department of Psychiatry, Gongju National Hospital) ;
  • Jonggook, Lee (Department of Psychiatry, Gongju National Hospital) ;
  • Jeong Seok, Seo (Department of Psychiatry, College of Medicine, Chung-Ang University) ;
  • Juhyun, Kim (Department of Psychiatry, Korean Institute of Enneagram & Psychodrama) ;
  • Keun, Oh (Department of Psychiatry, Gongju National Hospital) ;
  • Taehyun, Kim (Department of Psychiatry, Korean Institute of Enneagram & Psychodrama)
  • 김종현 (국립공주병원 정신건강의학과) ;
  • 이종국 (국립공주병원 정신건강의학과) ;
  • 서정석 (중앙대학교 의과대학 정신건강의학교실) ;
  • 김주현 (한국애니어드라마연구원 정신건강의학과) ;
  • 오근 (국립공주병원 정신건강의학과) ;
  • 김태현 (한국애니어드라마연구원 정신건강의학과)
  • Received : 2022.10.14
  • Accepted : 2022.11.02
  • Published : 2022.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : The purpose of this study was to quantitatively assess the degree of Graves' Disease affecting mental health through the results of multiphasic military personality inventory (MPI) in 19-year-old men. Methods : We collected and analyzed the results of the MPI for 592 healthy subjects and 148 Graves' disease patients among the 19-year-old men who visited the Military Manpower Administration from February 2008 to January 2010. Results : Among demographic characteristics, both Graves' disease and control group are 19-year-old men. Educational level, socioeconomic status, parental relationship, and BMI were not statistically different between the two groups (χ2=0.089, p=0.766; χ2=5.090, p=0.278; χ2=5.988, p=0.112 ; t=-0.635, p=0.526). In the MPI, among validity scales, the score of the faking-good subscale was significantly lower in the Graves' group (t=3.507, p<0.001), but in the faking-bad and infrequency subscales scores were not significantly different between two groups (t=-1.700, p=0.090; t=-0.519, p=0.604). Among the neurosis scale, anxiety, depression, somatization, and personality disorder subscale scores were all significantly higher in Graves' disease group (t=-3.323, p<0.001; t=-4.210, p<0.001; t=-6.202, p<0.001; t=-2.872, p<0.01). Among the psychopath scale, each score of schizophrenia and paranoia subscales were not statistically different between the two groups (t=-0.158, p=0.874; t=-0.846, p=0.398). Conclusions : According to MPI result, we can confirm that Graves' disease patients in 19-year-old-men may appear features such as anxiety, depression, somatization and personality tendency (introversion or impulsivity) than the control group.

연구목적 본 연구는 19세 남자에서 그레이브스병이 정신건강에 영향을 미치는 정도를 다면적 인성검사인 군인성검사(Military Personality Inventory, MPI) 결과를 통해 정량적으로 확인하고자 하였다. 방 법 우리는 2008년 2월부터 2010년 1월까지 병무청으로 군 신체검사를 받으러 방문한 19세 남자 중 다른 내외과 및 정신건강의학과 질환이 없는 건강한 대상자들 592명과 그레이브스병으로 확진된 대상자들 148명의 MPI 결과를 수집하고 분석하였다. 결 과 인구학적 특징에서 대상자들은 19세 남자로 나이와 성별이 동일하였으며, 교육수준, 사회경제적 상태, 부모관계, BMI 모두에서 그레이브스병 환자군과 정상대상자군 사이에 차이가 없었다(χ2=0.089, p=0.766; χ2=5.090, p=0.278; χ2=5.988, p=0.112; t=-0.635, p=0.526). 다면적 MPI 결과에서 타당도 척도에서는 긍정왜곡(fakinggood) 하위 척도 점수가 환자군에서 유의하게 낮았고(t=3.507, p<0.001), 부정왜곡(faking-bad) 하위척도 점수와 희귀도(infrequency) 하위 척도 점수는 두 군 간의 유의한 차이가 없었다(t=-1.700, p=0.090; t=-0.519, p=0.604). 신경증 척도에서는 불안(anxiety), 우울(depression), 신체화(somatization), 인격장애(personality disorder) 하위척도 점수가 모두 환자군에서 유의하게 높았다(t=-3.323, p<0.001; t=-4.210, p<0.001; t=-6.202 p<0.001; t=-2.872, p<0.01). 정신증 척도에서는 조현병 및 편집증 하위 척도 점수 모두 두 군 간의 유의한 차이가 없었다(t=-0.158, p=0.874; t=-0.846, p=0.398). 결 론 MPI 결과로 미루어 볼 때, 19세 남자에서 그레이브스병 환자는 정상대상자보다 불안 및 우울 수준이 더 높았으며, 신체적 염려 또는 증상을 더욱 호소하였고, 내향성이나 충동성과 같은 성격장애 성향이 더욱 나타났다.

Keywords

References

  1. Leger J. Graves' disease in children. Paediatric Thyroidology, Evnod Dev Basel, Karger 2014;26:171-182.  https://doi.org/10.1159/000363163
  2. Boelaert K, Torlinska B, Holder RL, Franklyn JA. Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study. J Clin Endocrinol Metab 2010;95:2715-2726.  https://doi.org/10.1210/jc.2009-2495
  3. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN; American Thyroid Association; American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011;21:593-646.  https://doi.org/10.1089/thy.2010.0417
  4. Nystrom HF, Jansson S, Berg G. Incidencerate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005. Clin Endocrinol (Oxf) 2013;78:768-776.  https://doi.org/10.1111/cen.12060
  5. Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am 1998;27:109-126.  https://doi.org/10.1016/s0889-8529(05)70302-9
  6. Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves' disease: a populationbased study of two Danish twin cohorts. J Clin Endocrinol Metab 1994;130:565-568. 
  7. Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001;86:930-934.  https://doi.org/10.1210/jcem.86.2.7242
  8. Ferrari SM, Fallahi P, Antonelli A, Benvenga S. Environmental issues in thyroid diseases. Front Endocrinol (Lausanne) 2017;8:50. 
  9. Bartalena L, Marcocci C, Pinchera A. Graves' ophthalmopathy: a preventable disease? Eur J Endocrinol 2002;146:457-461.  https://doi.org/10.1530/eje.0.1460457
  10. Covelli D, Ludgate M. The thyroid, the eyes and the gut: a possible connection. J Endocrinol Investig 2017;40:567-576.  https://doi.org/10.1007/s40618-016-0594-6
  11. Saitoh O, Nagayama Y. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology 2006;147:2417-2422.  https://doi.org/10.1210/en.2005-1024
  12. Fukao A, Takamatsu J, Murakami Y, Sakane S, Miyauchi A, Kuma K, Hayashi S, Hanafusa T. The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease. Clinical Endocrinology 2003;58:550-555.  https://doi.org/10.1046/j.1365-2265.2003.01625.x
  13. Mizokami T, Li AW, El-Kaissi S, Wall JR. Stress and thyroid autoimmunity. Thyroid 2004;14:1047-1055.  https://doi.org/10.1089/thy.2004.14.1047
  14. Fukao A, Takamatsu J, Miyauchi A, Hanafusa T. Stress and thyroid disease ISBN: 978-1-922227-78-2 Endocrine diseases, iConcept Press;2014. 
  15. Demet MM, Ozmen B, Deveci A, Boyvada S, Adiguzel H, Aydemir O. Depression and anxiety in hyperthyroidism. Arch Med Res 2002;33:552-556.  https://doi.org/10.1016/S0188-4409(02)00410-1
  16. MacCrimmon DJ, Wallace JE, Goldberg WM, Streiner DL. Emotional disturbance and cognitive deficits in hyperthyroidism. Psychosom Med 1979;41:331-340.  https://doi.org/10.1097/00006842-197906000-00007
  17. Whybrow PC, Prange Jr AJ, Treadway CR. Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement. Arch Gen Psychiatry 1969;20:48-63.  https://doi.org/10.1001/archpsyc.1969.01740130050004
  18. Wallace JE, MacCrimmon DJ, Goldberg WM. Acute hyperthyroidism: cognitive and emotional correlates. J Abnorm Psychol 1980;89:519-527.  https://doi.org/10.1037/0021-843X.89.4.519
  19. Zeitlhofer J, Saletu B, Stary J, Ahmadi R. Cerebral function in hyperthyroid patients. Psychopathology, psychometric variables, central arousal and time perception before and after thyreostatic therapy. Neuropsychobiology 1984;11:89-93.  https://doi.org/10.1159/000118059
  20. Bennett B, Mansingh A, Fenton C, Katz. Graves' disease presenting with hypomania and paranoia to the acute psychiatry service. BMJ Case Rep 2021;14:e236089.  https://doi.org/10.1136/bcr-2020-236089
  21. Bunevicius R, Arthur J, Prange Jr. Psychiatric manifestations of graves' hyperthyroidism pathophysiology and treatment options. CNS Drugs 2006;20:897-909.  https://doi.org/10.2165/00023210-200620110-00003
  22. Fukao A, Takamatsu J, Arishima T, Tanaka M, Kawai T, Okamoto Y, Miyauchi A, Imagawa A. Graves' disease and mental disorders. J Clin Transl Endocrinol 2020;19:1-8. 
  23. Brownlie BEW, Rae AM, Walshe JWB, Wells J. Psychoses associated with thyrotoxicoses. "Thyrotoxic psychoses": a report of 18 cases, with statistical analysis of incidence. Eur J Endocrinol 2000;142:438-444.  https://doi.org/10.1530/eje.0.1420438
  24. Scheffer C, Heckmann C, Mijic T, Rudorff KH. Chronic distress syndrome in patients with Graves' disease. Med Klin (Munich) 2004;99:578-584.  https://doi.org/10.1007/s00063-004-1089-3
  25. Draganic-Gajic S, Lecic-Tosevski D, Svrakic D, Paunovic VR, Cvejic V, Cloninger R. Psychosomatic concept of hyperthyroidism-Graves type-behavioral and biochemical characteristics. Med Pregl 2008;61:383-388.  https://doi.org/10.2298/MPNS0808383D
  26. Boiko J, Leger J, Raux-Demay MC, Cabrol S, Le Bouc Y, Czernichow P. Basedow disease in children: clinical and evolutive aspects. Arch Pediatr 1998;5:722-730.  https://doi.org/10.1016/S0929-693X(98)80052-3
  27. Zimmerman D, Gan-Gaisano M. Hyperthyroidism in children and adolescents. Pediatr Clin North Am 1993;37:1273-1295.  https://doi.org/10.1016/s0031-3955(16)37011-0
  28. Bruscolini A, Sacchetti M, Cava ML, Nebbioso M, Iannitelli A, Quartini A, Lambiase A, Ralli M, Virglio A, Greco A. Quality of life and neuropsychiatric disorders in patients with Graves' orbitopathy: current concepts. Autoimmun Rev 2018;17:639-643.  https://doi.org/10.1016/j.autrev.2017.12.012
  29. Hathaway SR, McKinley JC. The Minnesota multiphasic personality inventory, Rev. ed., 2nd printing;1943. 
  30. Subotnik KL, Asarnow RF, Nuechterlein KH, Fogelson DL, Thorpe TI, Payne DL, Giannini CA, Kuppinger HE, Torquato RD, Mintz J, Hwang SS, Gottesman II. MMPI vulnerability indicators for schizophrenia and attention deficit disorder: UCLA family study of biological parents of offspring with childhood-onset schizophrenia or ADHD. Behav Genet 2005;35:159-175.  https://doi.org/10.1007/s10519-004-1016-7
  31. Wolf EJ, Miller MW, Orazem RJ, Weierich MR, Castillo DT, Milford J, Danny GK, Terence M. The MMPI-2 Restructured Clinical Scales in the assessment of posttraumatic stress disorder and comorbid disorders. Psychol Assess 2008;20:327.  https://doi.org/10.1037/a0012948
  32. Kim SK, Kim T, Seo JS, Moon SW, Kim TH, Lee J, Nam B. Result of multiphasic personality inventory among people with scoliosis: retrospective cross-sectional analysis of military candidate in Korea. J Korean Neuropsychiatr Assoc 2017;56:181-185.  https://doi.org/10.4306/jknpa.2017.56.4.181
  33. Won HT HD, Sin ES, Park KB, Lee YH, Yuk SP. Final report on development study of military personality inventory. Seoul: Korean Psychol Assoc;1998. 
  34. Choi KH JS, Choi KP, Moon CB, Kim JM. Development of new military personality inventory. Seoul: Korea Institute for Defense Analyses;2009. 
  35. Kim T, Kim JJ, Kim MY, Kim SK, Roh S, Seo JS. Erratum: A U-shaped Association between body mass index and psychological distress on the multiphasic personality inventory: retrospective cross-sectional analysis of 19-year-old men in Korea. J Korean Med Sci 2015;30:1537.  https://doi.org/10.3346/jkms.2015.30.10.1537
  36. Lane LC, Rankin J, Cheetham T. A survey of the young person's experience of Graves' disease and its management. Clin Endocrinol 2021;94:330-340.  https://doi.org/10.1111/cen.14359
  37. Kahaly GJ. Socioeconomic Impact. Wiersinga WM, Kahaly GJ (eds). Graves' Orbitopathy. A Multidisciplinary Approach-Questions and Answers. Basel, Karger;2017. p.275-284. 
  38. Winsa B, Adami HO, Bergstrom R, Gamstedt A, Dahlberg PA, Adamson U, Jansson R, Karlsson A. Stressful life events and Graves' disease. Lancet 1991;338:1475-1479.  https://doi.org/10.1016/0140-6736(91)92298-G
  39. Alonso GT, Rabon S, White PC. Weight gain after treatment of Graves' disease in children. Clinical Endocrinology 2018;88:66-70.  https://doi.org/10.1111/cen.13493
  40. Carta MG, Loviselli A, Hardoy MC, Massa S, Cadeddu M, Sardu C, Carpiniello B, Osso L, Mariotti S. The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. BMC Psychiatry 2004;4:25.  https://doi.org/10.1186/1471-244X-4-25
  41. Stern RA, Robinson B, Thorner AR, Arruda JE, Prohaska ML, Prange AJ Jr. A survey study of neuropsychiatric complaints in patients with Graves' disease. J Neuropsychiatry Clin Neurosci 1996;8:181-185. https://doi.org/10.1176/jnp.8.2.181